Effect of Eudragit RS 30D and talc powder on verapamil hydrochloride release from beads coated with drug layered matrices
- PMID: 18446464
- PMCID: PMC2976883
- DOI: 10.1208/s12249-007-9008-6
Effect of Eudragit RS 30D and talc powder on verapamil hydrochloride release from beads coated with drug layered matrices
Abstract
The aim of this study was to investigate the effect of Eudragit RS 30D, talc, and verapamil hydrochloride on dissolution and mechanical properties of beads coated with "drug-layered matrices". This was accomplished with the aid of a three-factor multiple-level factorial design using percent drug release in 1 and 2 h, T(50), tensile strength, brittleness, stiffness and toughness as the responses. Beads were coated in a fluidized-bed coating unit. Surface morphology and mechanical properties were evaluated by surface profilometry and texture analysis, respectively. No cracks, flaws and fissures were observed on the surfaces. The mechanical properties were dependent on the talc/polymer ratio. The release of verapamil from the beads was influenced by matrix components. Increasing the level of both talc and Eudragit decreased the percent drug released from 67% to 4.8% and from 80.7% to 6.7% in 1 and 2 h, respectively, and increased T(50) from 0.8 to 25.7 h. It was concluded that beads could be efficiently coated with "drug-layered matrices". The release of drug, however, depends on a balance between the levels of drug, talc, and polymer, whereby desired dissolution and mechanical properties could be controlled by the talc/polymer ratio and the level of drug loading.
Figures







Similar articles
-
Novel use of Eudragit NE 30D/Eudragit L 30D-55 blends as functional coating materials in time-delayed drug release applications.Int J Pharm. 2008 Jun 5;357(1-2):219-27. doi: 10.1016/j.ijpharm.2008.02.003. Epub 2008 Feb 13. Int J Pharm. 2008. PMID: 18353571
-
Dissolution stability studies of suspensions of prolonged-release diclofenac microcapsules prepared by the Wurster process: I. Eudragit-based formulation and possible drug-excipient interaction.J Microencapsul. 2005 Jun;22(4):333-42. doi: 10.1080/02652040500100600. J Microencapsul. 2005. PMID: 16214782
-
Development of metoprolol tartrate-loaded sustained-release pellets: effect of talc on the mechanism of drug release.Pharm Dev Technol. 2018 Sep;23(7):664-673. doi: 10.1080/10837450.2016.1212881. Epub 2016 Jul 28. Pharm Dev Technol. 2018. PMID: 27470125
-
pH-Sensitive polymer blends used as coating materials to control drug release from spherical beads: elucidation of the underlying mass transport mechanisms.Pharm Res. 2005 Jul;22(7):1129-41. doi: 10.1007/s11095-005-5421-2. Epub 2005 Jul 22. Pharm Res. 2005. PMID: 16028014
-
Preparation of microparticles of naproxen with Eudragit RS and talc by spherical crystallization technique.Pharm Dev Technol. 2009;14(4):442-50. doi: 10.1080/10837450902748404. Pharm Dev Technol. 2009. PMID: 19235551
Cited by
-
From Oral to Sublingual: A Redefined Avanafil Tablet with a Breakthrough in Bioavailability and First-Pass Metabolism Avoidance.Drug Des Devel Ther. 2025 Apr 3;19:2551-2576. doi: 10.2147/DDDT.S504291. eCollection 2025. Drug Des Devel Ther. 2025. PMID: 40196752 Free PMC article.
-
Formulation development and evaluation, in silico PBPK modeling and in vivo pharmacodynamic studies of clozapine matrix type transdermal patches.Sci Rep. 2025 Jan 7;15(1):1204. doi: 10.1038/s41598-024-81918-6. Sci Rep. 2025. PMID: 39774012 Free PMC article.
-
Impact of anti-tacking agents on properties of gas-entrapped membrane and effervescent floating tablets.AAPS PharmSciTech. 2014 Dec;15(6):1357-69. doi: 10.1208/s12249-014-0161-4. Epub 2014 Jun 14. AAPS PharmSciTech. 2014. PMID: 24927669 Free PMC article.
References
-
- T. Osawa, T. Takahata, H. Takahata, M. Maejima, M. Kbayashi, T. Noda. Sigmoidal releasing system (SRS) as a novel oral controlled release formulation. Proceedings of the Oral Controlled Release Formulation, 1991, pp 405–406.
-
- Follonier N., Doelker E. Biopharmaceutical comparison of oral multiple-unit and single unit sustained release dosage forms. S.T.P. Pharma Sci. 1992;2:141–158.
-
- Vaithiyalingam S., Reddy I. K., Khan M. A. Aquoeous-based cellulose acetate butyrate dispersion: Screening of process and formulation variables to obtain verapamil HCL-controlled release beads. Part. Sci. Tech. 2001;19:131–144. doi: 10.1080/02726350152772074. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources